A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women - 24/04/13
Correspondence to: Amit G. Pandya, MD, Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9190.Abstract |
Background |
Melasma, a common disorder of hyperpigmentation, is often resistant to therapy. Although salicylic acid peels have been reported to be useful for patients with recalcitrant melasma, controlled trials are lacking.
Objective |
We sought to determine the efficacy of salicylic acid peels when added to hydroquinone in the treatment of melasma.
Methods |
Twenty Latin American women with moderate to severe bilateral melasma were treated with a series of 20% to 30% salicylic acid peels every 2 weeks for a total of 4 peels on one side of the face along with 4% hydroquinone cream to both sides of the face twice daily. The primary efficacy variable was reduction in pigmentation of the peeled side compared with the unpeeled side using narrowband reflectance spectrophotometry.
Results |
Eighteen patients completed the study. Although both sides had significant reduction in pigment intensity, there was no difference between the peeled and unpeeled side with all outcome measures.
Limitations |
Patients were limited to Latin American women and only 4 peels were performed.
Conclusion |
A series of four 20% to 30% salicylic acid peels are not effective in the treatment of melasma when added to twice-daily 4% hydroquinone cream.
Le texte complet de cet article est disponible en PDF.Key words : hydroquinone, Latin American, melasma, peels, pigmentation, salicylic acid
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 63 - N° 6
P. 1030-1035 - décembre 2010 Retour au numéro
Article précédent
- IgM in lesional skin of adults with Henoch-Schönlein purpura is an indication of renal involvement
- Sora Takeuchi, Yoshinao Soma, Tamihiro Kawakami
- Treatment of pachydermoperiostosis pachydermia with botulinum toxin type A
- Samer Ghosn, Imad Uthman, Maurice Dahdah, Abdul Ghani Kibbi, Nelly Rubeiz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?